Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome: a randomized, controlled trial

Harry Pickering, John D. Hart, Sarah Burr, Richard Stabler, Ken Maleta, Khumbo Kalua, Robin L. Bailey, Martin J. Holland
doi: https://doi.org/10.1101/2021.03.02.20215632

Article Information

doi 
https://doi.org/10.1101/2021.03.02.20215632
History 
  • March 3, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Harry Pickering1,*,
  2. John D. Hart1,
  3. Sarah Burr1,2,
  4. Richard Stabler1,
  5. Ken Maleta2,
  6. Khumbo Kalua2,3,
  7. Robin L. Bailey1 and
  8. Martin J. Holland1
  1. 1London School of Hygiene and Tropical Medicine, London, UK
  2. 2College of Medicine, University of Malawi, Blantyre, Malawi
  3. 3Blantyre Institute for Community Outreach, Blantyre, Malawi
  1. ↵*Corresponding author; email: harrycpickering{at}gmail.com
Back to top
Posted March 03, 2021.
Download PDF
Data/Code
Email
Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome: a randomized, controlled trial
Harry Pickering, John D. Hart, Sarah Burr, Richard Stabler, Ken Maleta, Khumbo Kalua, Robin L. Bailey, Martin J. Holland
medRxiv 2021.03.02.20215632; doi: https://doi.org/10.1101/2021.03.02.20215632
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area